These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 20692450
1. Frozen-section diagnosis in donor livers: error rate estimation of steatosis degree. D'Alessandro E, Calabrese F, Gringeri E, Valente M. Transplant Proc; 2010; 42(6):2226-8. PubMed ID: 20692450 [Abstract] [Full Text] [Related]
2. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. Fiorentino M, Vasuri F, Ravaioli M, Ridolfi L, Grigioni WF, Pinna AD, D'Errico-Grigioni A. Liver Transpl; 2009 Dec; 15(12):1821-5. PubMed ID: 19938115 [Abstract] [Full Text] [Related]
3. Use of severely steatotic grafts in liver transplantation: a matched case-control study. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095 [Abstract] [Full Text] [Related]
8. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. de Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D, Pleass H, Crawford M, McCaughan GW, Verran DJ. J Gastroenterol Hepatol; 2012 Mar; 27(3):540-6. PubMed ID: 21777274 [Abstract] [Full Text] [Related]
9. Effect of graft steatosis on liver function and organ survival after liver transplantation. Angele MK, Rentsch M, Hartl WH, Wittmann B, Graeb C, Jauch KW, Loehe F. Am J Surg; 2008 Feb; 195(2):214-20. PubMed ID: 18154767 [Abstract] [Full Text] [Related]
10. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27. Avolio AW, Frongillo F, Nicolotti N, Mulè A, Vennarecci G, De Simone P, Agnes S. Transplant Proc; 2009 Feb; 41(1):208-12. PubMed ID: 19249515 [Abstract] [Full Text] [Related]
12. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M. Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805 [Abstract] [Full Text] [Related]
18. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation. Botha JF, Thompson E, Gilroy R, Grant WJ, Mukherjee S, Lyden ER, Fox IJ, Sudan DL, Shaw BW, Langnas AN. Liver Int; 2007 Aug 27; 27(6):758-63. PubMed ID: 17617118 [Abstract] [Full Text] [Related]
19. Safety of donors with fatty liver in liver transplantation. Kwon CH, Joh JW, Lee KW, Kim SJ, Han YS, Park JW, Kim DJ, Park JB, Lee SK. Transplant Proc; 2006 Sep 27; 38(7):2106-7. PubMed ID: 16980014 [Abstract] [Full Text] [Related]
20. Steatosis in donor and transplant liver biopsies. Crowley H, Lewis WD, Gordon F, Jenkins R, Khettry U. Hum Pathol; 2000 Oct 27; 31(10):1209-13. PubMed ID: 11070113 [Abstract] [Full Text] [Related] Page: [Next] [New Search]